Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

about

How Open Data Shapes In Silico Transporter Modeling.The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion.In silico ADME-Tox modeling: progress and prospects.

P2860

Q30491084-5C25AEB3-20A2-4809-AC5F-0CE57949B58C Q42698532-7E55C171-5B57-4D01-BA8E-84DF2E202657 Q47658021-5F8A9ACD-7494-4F2A-BEE4-655E0D0BC7EB

P2860

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

Item

http://www.wikidata.org/entity/Q57009464

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2017

@uk

name

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

@en

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

@nl

type

Item

label

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

@en

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

@nl

prefLabel

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

@en

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

@nl

P1476

Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

@en

P2093

Anna Cseke

http://www.w3.org/2001/XMLSchema#string

Gerhard F Ecker

http://www.w3.org/2001/XMLSchema#string

Katrin Wlcek

http://www.w3.org/2001/XMLSchema#string

P2860

The ChEMBL bioactivity database: an update

PubChem's BioAssay Database.

Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease

BCRP Inhibition: from Data Collection to Ligand-Based Modeling.

Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer.

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs.

Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.

A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.

Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design.

Identification of novel breast cancer resistance protein (BCRP) inhibitors by virtual screening.

P304

86-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1087057116657513

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Floriane Montanari

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27401583

http://www.w3.org/2001/XMLSchema#string

P932

5302078

http://www.w3.org/2001/XMLSchema#string